SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Launches Investigation Into Zenas BioPharma, Inc. (NASDAQ: ZBIO)

Purcell & Lefkowitz LLP, a New York–based law firm representing investors, has announced a formal shareholder investigation into Zenas BioPharma, Inc. (NASDAQ: ZBIO) on behalf of the company’s stockholders. The firm is examining whether the directors of Zenas BioPharma breached their fiduciary duties in connection with recent corporate actions that may have harmed shareholders. The investigation seeks facts and potential legal claims tied to decisions made by the company’s leadership. Shareholders who believe they have been affected are encouraged to learn more about their rights and options by visiting the firm’s dedicated webpage. Interested parties can contact attorney Robert H. Lefkowitz directly via email or by calling the firm’s office. One of the firm’s attorneys will discuss the case with shareholders at no cost or obligation. Purcell & Lefkowitz LLP specializes in representing investors who may be victims of securities fraud, breaches of fiduciary duty, and other forms of corporate misconduct. #ZenasBioPharma #ShareholderInvestigation #FiduciaryDuty #PurcellLefkowitz #SlimScan #GrowthStocks #CANSLIM